Advocacy intelligence hub — real-time data for patient organizations
Disc Medicine, Inc — PHASE3
Portal Therapeutics, Inc. — PHASE2
The University of Texas Medical Branch, Galveston
Nordlandssykehuset HF
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Karl E Anderson, MD
University of Texas
Eliane Sardh, MD PhD
Karolinska University Hospital, Stockholm
Karl E Anderson
University of Texas
Amy K Dickey, MD
Massachusetts General Hospital
Manisha Balwani, MD, M.D., M.S
Icahn School of Medicine at Mount Sinai
📍 NEW YORK, NY
Pilar Bilbao
Clinuvel Pharmaceuticals Limited
View all Disorder of porphyrin and heme metabolism specialists →